Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Radnor, Pennsylvania–(Newsfile Corp. – January 3, 2025) – The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a lawsuit has been filed against Kyverna Therapeutics, Inc. . (“Kyverna”) (NASDAQ: KYTX) for the benefit of those who purchased Kyverna common stock pursuant to/or may be followed by Kyverna’s February 8, 2024 initial public offering (“IPO”). The claimant’s deadline is March 7, 2025.
Contact KESSLER TOPAZ MELTZER & CHECK, LLP:
If you missed Kyverna, you can CLICK HERE or copy and paste this link into your browser: https://www.ktmc.com/new-cases/kyverna-therapeutics-inc?utm_source=PR&utm_medium=link&utm_campaign=kytx&mktm=r
You can also contact attorney Jonathan Naji, Esq. by calling (484) 270-1453 or by email at info@ktmc.com.
OFFICERS WHO REPORT MISCONDUCT:
The Complaint alleges that, in the prospectus and registration statements issued in connection with the IPO, the Defendants made false and/or misleading statements and/or omissions about the company’s business, operations and prospects. Specifically, the Defendants made false and/or misleading statements regarding, and/or failed to disclose, that Kyverna had adverse events related to one of its trials clinical at the time of its IPO.
PREVIOUS MONTHLY PROCEDURE:
My Kyverna Investors, before 7 March 2025, seek to be appointed as the lead representative of the class plaintiff by Kessler Topaz Meltzer & Check, LLP or other counsel, or may choose to do nothing and remain a member of the absent class. The lead plaintiff is the representative who represents all the members of the class to conduct the case. The lead plaintiff is usually an investor or a small group of investors who have a significant financial interest and who are also equal and common to the proposed class of investors. The lead plaintiff appoints counsel to represent the lead plaintiff and the class and these attorneys, if approved by the court, are lead or class counsel. Your ability to participate in any recovery is not affected by whether or not you will serve as the lead plaintiff.
Kessler Topaz Meltzer & Check, LLP encourages Kyverna investors who have experienced significant losses to contact the firm directly for more information.
CLICK HERE TO REGISTER FOR THE CAKE OR COPY AND PASTE THIS LINK TO YOUR SITE: https://www.ktmc.com/new-cases/kyverna-therapeutics-inc?utm_source=PR&utm_medium=link&utm_campaign=kytx&mktm=r
ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP:
Kessler Topaz Meltzer & Check, LLP litigates class actions in federal and state courts throughout the country and around the world. The firm has an international reputation and has recovered billions of dollars for victims of fraud and other business disputes. All of our work is driven by one goal: to protect investors, customers, employees and others from fraud, abuse, misconduct and negligence by businesses and individuals. The complaint in this action was filed by Kessler Topaz Meltzer & Check, LLP. For more information about Kessler Topaz Meltzer & Check, LLP please visit www.ktmc.com.
LEARN:
May be considered a marketing attorney in certain areas. Past results do not guarantee future results.
To view the source version of this release, please visit https://www.newsfilecorp.com/release/235393
